Novartis Beats Failure-To-Warn Suit Over Zometa, Jury Rules
By Sindhu Sundar ( June 26, 2013, 10:43 PM EDT) -- Novartis Pharmaceuticals Corp. defeated a cancer patient's claims that she suffered a jaw disease after taking its cancer therapy drug Zometa when a California federal jury found that the drugmaker was not liable for failure to warn of such side effects. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.